Mark R. Brann

12.2k total citations · 4 hit papers
112 papers, 10.3k citations indexed

About

Mark R. Brann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark R. Brann has authored 112 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 55 papers in Cellular and Molecular Neuroscience and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark R. Brann's work include Receptor Mechanisms and Signaling (82 papers), Neuropeptides and Animal Physiology (27 papers) and Protein Kinase Regulation and GTPase Signaling (19 papers). Mark R. Brann is often cited by papers focused on Receptor Mechanisms and Signaling (82 papers), Neuropeptides and Animal Physiology (27 papers) and Protein Kinase Regulation and GTPase Signaling (19 papers). Mark R. Brann collaborates with scholars based in United States, Canada and Denmark. Mark R. Brann's co-authors include Noel J. Buckley, T I Bonner, Tom I. Bonner, David M. Weiner, Alice C. Young, Allan I. Levey, Tracy A. Spalding, Ethan S. Burstein, W. Scott Young and Frank Dörje and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark R. Brann

111 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Family of Muscarinic Acetylcholine Receptor Genes

1987 1.3k citations Tom I. Bonner, Noel J. Buckley et al. profile →
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.

1986 676 citations T I Bonner, Mark R. Brann et al. profile →
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.

1989 574 citations Noel J. Buckley, T I Bonner et al. Molecular Pharmacology profile →
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

1990 549 citations J. Wess, Mark R. Brann et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Countries citing papers authored by Mark R. Brann

Since Specialization

Citations

This map shows the geographic impact of Mark R. Brann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Brann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Brann more than expected).

Fields of papers citing papers by Mark R. Brann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Brann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Brann. The network helps show where Mark R. Brann may publish in the future.

Co-authorship network of co-authors of Mark R. Brann

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Brann. A scholar is included among the top collaborators of Mark R. Brann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Brann. Mark R. Brann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of novel selective V2 receptor non-peptide agonists 2008 ·Biochemical Pharmacology ·Andria L. Del Tredici, K.E. Vanover, (unknown), Sine Mandrup Bertozzi, Norman Nash, Ethan S. Burstein, Jelveh Lameh, Erika A. Currier, Robert E. Davis, Mark R. Brann, Nina Mohell, Roger Olsson, Fabrice Piu	5
2	Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors 2007 ·Molecular Pharmacology ·Remko A. Bakker, Aldo Jongejan, Kamonchanok Sansuk, Uli Hacksell, Henk Timmerman, Mark R. Brann, (unknown), Leonardo Pardo, Rob Leurs	23
3	Monitoring Interactions between Receptor Tyrosine Kinases and Their Downstream Effector Proteins in Living Cells Using Bioluminescence Resonance Energy Transfer 2007 ·Molecular Pharmacology ·Philip K. Tan, Jean Wang, (unknown), Kenneth K. Wong, (unknown), (unknown), Norman Nash, (unknown), Fabrice Piu, Mark R. Brann, Hans H. Schiffer	18
4	8R-Lisuride Is a Potent Stereospecific Histamine H1-Receptor Partial Agonist 2004 ·Molecular Pharmacology ·Remko A. Bakker, (unknown), Antonius ter Laak, Thijs Beuming, Obbe P. Zuiderveld, (unknown), Uli Hacksell, H. Timmerman, Mark R. Brann, Rob Leurs	24
5	Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, (unknown), Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo‐Ragnar Tolf, Mark R. Brann, Uli Hacksell, Robert E. Davis	18
6	Discovery of an Ectopic Activation Site on the M₁Muscarinic Receptor 2002 ·Molecular Pharmacology ·Tracy A. Spalding, Carol Trotter, Niels Skjærbæk, Terri Messier, Erika A. Currier, Ethan S. Burstein, Donghui Li, Uli Hacksell, Mark R. Brann	156
7	Chemical genomics: massively parallel technologies for rapid lead identification and target validation 2002 ·Cytotechnology ·Uli Hacksell, Norman Nash, Ethan S. Burstein, Fabrice Piu, Glenn Croston, Mark R. Brann	4
8	Functional Importance of the Ala116–Pro136 Region in the Calcium-sensing Receptor 2000 ·Journal of Biological Chemistry ·Anders A. Jensen, Tracy A. Spalding, Ethan S. Burstein, Paul O. Sheppard, Patrick J. O’Hara, Mark R. Brann, Povl Krogsgaard‐Larsen, Hans Bräuner‐Osborne	56
9	The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors 1998 ·Oncogene ·Ethan S. Burstein, (unknown), J. Silvio Gutkind, Mark R. Brann, Erika A. Currier, Terri Messier	23
10	The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling 1998 ·Journal of Biological Chemistry ·Ethan S. Burstein, Tracy A. Spalding, Mark R. Brann	110
11	A Serotonin Receptor Gene (5HT1A) Variant Found in a Tourette's Syndrome Patient 1996 ·Biochemical and Biophysical Research Communications ·(unknown), Yang Shen, Tuan Nguyen, Terri Messier, Mark R. Brann, David E. Comings, Susan R. George, Brian F. O’Dowd	40
12	Annulated Heterocyclic Bioisosteres of Norarecoline. Synthesis and Molecular Pharmacology at Five Recombinant Human Muscarinic Acetylcholine Receptors 1995 ·Journal of Medicinal Chemistry ·Hans Bräuner‐Osborne, Bjarke Ebert, Mark R. Brann, E. FALCH, Povl Krogsgaard‐Larsen	13
13	High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian Cells 1995 ·Pharmacology & Toxicology ·Terri Messier, Christine M. Dorman, Hans Bräuner‐Osborne, (unknown), Mark R. Brann	21
14	Chapter 12: Muscarinic acetylcholine receptor subtypes: localization and structure/function 1993 ·Progress in brain research ·Mark R. Brann, John E. Ellis, (unknown), David C. Hill‐Eubanks, S V Jones	84
15	Studies of the Pharmacology, Localization, and Structure of Muscarinic Acetylcholine Receptors^a 1993 ·Annals of the New York Academy of Sciences ·Mark R. Brann, (unknown), Ethan S. Burstein, Tracy A. Spalding, John E. Ellis, S V Jones, David C. Hill‐Eubanks	18
16	Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. 1991 ·The EMBO Journal ·J. Wess, David A. Gdula, Mark R. Brann	127
17	Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 1990 ·Nature ·Roger K. Sunahara, Hyman B. Niznik, David M. Weiner, (unknown), Mark R. Brann, James L. Kennedy, Joel Gelernter, Richard Rozmahel, Yili Yang, Yedy Israel, Philip Seeman, Brian F. O’Dowd	375
18	Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover 1989 ·FEBS Letters ·Jürgen Wess, Mark R. Brann, Tom I. Bonner	93
19	The distribution of a dopamine D2 receptor mRNA in rat brain 1989 ·FEBS Letters ·David M. Weiner, Mark R. Brann	84
20	Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses. 1988 ·Molecular Pharmacology ·S V Jones, J L Barker, Noel J. Buckley, T I Bonner, R. M. Collins, Mark R. Brann	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact